Expert review of anticancer therapy
Impact of renin-angiotensin system inhibitors on the clinical outcomes of nivolumab therapy in metastatic non-small cell lung cancer.
Emel Mutlu Ozkan, Ibrahim Karadağ, Elif Sahın, Ayse Nuransoy Cengiz, Muhammet Cengız, Deniz Can Guven, Oktay Bozkurt, Mevlüde Inanç, Metin Ozkan, Umut Kefelı, Devrim Cabuk, Mustafa Erman, Saadettin Kılıckap, Tolga Kosecı, Duygu Bayır
Published: 202610.1080/14737140.2026.2615853
Abstract
BACKGROUND: The objective of this study is to evaluate the correlation between survival outcomes and renin angiotensin system inhibitors (RASI) use in patients treated nivolmab with metastatic non-small cell lung cancer (mNSCLC). METHODS: This retros…
Preview only. Read the full abstract at the source